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Rationale  Dopamine synthesizing neurons are involved in a wide variety of functions. The 
most prominent dopamine pathways originate in the midbrain. The development, function and 
survival of these dopaminergic neurons are under the influence of numerous transcription and 
neurotrophic factors. Subtle differences in the genes encoding these factors may be of importance 
for several psychiatric and neurodegenerative disorders. LMX1A, LMX1B and PITX3 are 
transcription factors that are essential for the development, specification and survival of midbrain 
dopaminergic neurons. BDNF is a neurotrophic factor involved in neurodevelopmental 
processes including differentiation and survival of dopaminergic neurons. Another protein of 
importance for dopaminergic neurotransmission is the dopamine transporter (DAT) that 
mediates reuptake and inactivation of extracellular dopamine and is hence of fundamental 
importance in regulating dopamine transmission. The specific aim of this thesis was to 
investigate the possible influence of polymorphisms in these dopamine-related genes on 
dopamine-related disorders, i.e. Parkinson’s disease (PD), attention-deficit/hyperactivity 
disorder (ADHD), social anxiety disorder (SAD) and schizophrenia. Observat ions Three 
single nucleotide polymorphisms (SNPs) in LMX1A and one in LMX1B were associated with 
PD. After splitting for gender, six SNPs were associated with PD in women and four in men 
(Paper I). Two SNPs in PITX3 were associated with PD in patients with an early age of onset 
when compared either to controls or to PD patients with late onset (Paper II). One of the PITX3 
polymorphisms was also associated with schizophrenia, as were two polymorphisms in LMX1A, 
and one SNP in LMX1B (Paper III). We assessed longitudinal, quantitative phenotypes of 
hyperactivity-impulsivity and inattention, and found that the Met allele of the Val66Met 
polymorphism in the BDNF gene was associated with increased persistent hyperactivity-
impulsivity symptoms as well as with increased age-specific inattention symptoms (Paper IV). 
The amygdala, essential for detection of biologically relevant stimuli and fear generation, is 
under excitatory influence of dopamine. Positron emission tomography (PET) and functional 
magnetic resonance imaging (fMRI) were used to investigate if a variable number of tandem 
repeat (VNTR) polymorphism in the DAT gene (SLC6A3) influences amygdala function 
during processing of aversive emotional stimuli in SAD patients and healthy controls, 
respectively. The 9-repeat allele was associated with significantly increased amygdala activity, as 
assessed with PET, across tests (i.e. public speaking, processing of angry and neutral faces) in 
SAD patients, but with decreased amygdala activity in controls. Moreover, 9-repeat carriers, 
regardless of diagnosis, displayed augmented amygdala reactivity, i.e. a greater activation, of the 
left amygdala in response to angry compared to neutral faces. Blood oxygen level-dependent 
(BOLD) fMRI was used to assess healthy volunteers, and in line with the results from the PET 
study, 9-repeat carriers displayed higher reactivity of the left amygdala in response to angry 
faces, compared to neutral geometric shapes (Paper V). Conc lus ions All of the studies were 
based on a priori hypotheses regarding the possible relationship between the genes and the 
disorders under investigation. Some of the associations reported in this thesis have not been 
described earlier, others have been confirmed in independent samples, whereas in some cases, 
earlier studies have been inconclusive. In summary, our results support the notion that variation 
in dopamine-related genes is of importance for dopamine-related disorders and amygdala 
function. 
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